Biogen Idec, Inc. (BIIB) Reports Solid Q2 Results

July 24, 2012 7:00 AM EDT
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q2 EPS of $1.82, $0.26 better than the analyst estimate of $1.56. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.33 billion.

For earnings history and earnings-related data on Biogen Idec, Inc. (BIIB) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment